Euro Diagnostica’s goal is to constantly develop solutions to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune and related diseases. In July 2014 Euro Diagnostica entered into a merger agreement with Biomonitor, a leading company in theranostics and personalized medicine. Today, together with Biomonitor, Euro Diagnostica is providing a large portfolio of kits, laboratory and OEM/custom manufacturing services as well as drug monitoring and customized assay development for measurement of biological activity in various biological and biosimilar drugs.